EVALUATION OF CARBOXYMETHYL MILLET STARCH AND PREGELATINIZED MILLET STARCH AS PHARMACEUTICAL EXCIPIENTS USING FACTORIAL EXPERIMENTAL DESIGNS

Authors

  • YUSRA AHMED Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan https://orcid.org/0000-0001-9668-3069
  • ABDULLAH H. MAAD Department of Pharmaceutics, College of Pharmacy, University of Al-Ameed, Karbala, Iraq https://orcid.org/0000-0002-6009-5166
  • HASSAN ALI HASSAN Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan https://orcid.org/0000-0002-8008-3859
  • DAUD BARAKA ABDALLAH Department of Pharmaceutics, Faculty of Pharmacy, Al Ribat University, Khartoum, Sudan
  • MALAZ YOUSEF Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan
  • ABDUL AMIR H. KADHUM College of medicine, University of Al-Ameed, Karbala, Iraq
  • ZUHEIR OSMAN Department of Pharmaceutics, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan

DOI:

https://doi.org/10.22159/ijap.2025v17i2.52161

Keywords:

Millet starch, Factorial designs, Modification, Optimization, Paracetamol

Abstract

Objective: This study aimed to evaluate and optimize modified millet starches as pharmaceutical excipients in paracetamol tablet formulations, using factorial experimental designs to compare them against commonly used excipients in the industry.

Methods: Paracetamol tablets containing Carboxymethyl Millet Starch (CMMS) and Pregelatinized Millet Starch (PGMS) were evaluated through official quality control tests such as hardness, friability, disintegration time, and dissolution profile. Compatibility studies were performed using Fourier-Transform Infrared Spectroscopy (FTIR). The formulations were optimized based on statistical analysis using design expert V8.0.6.

Results: Tablets formulated with Carboxymethyl Millet Starch (CMMS) and Pregelatinized Millet Starch (PGMS) as excipients demonstrated a hardness range of 6.1–8.8 kg/cm² and disintegration times of 1.0–7.5 min. CMMS-based tablets showed slower drug release, reaching 80% release within 60 min. Statistical optimization indicated optimal binder concentrations of 6% for CMMS, resulting in a friability of 0.7%, hardness of 8.8 kg/cm², and disintegration time of 2.3 min, and 11% for PGMS, with a friability of 0.75%, hardness of 7.7 kg/cm², and disintegration time of 5.9 min. The optimized dissolution profile for PGMS formulations showed a similarity factor (f2) of 62, while CMMS tablets had an f2 value of 38 compared to Humadol.

Conclusion: The modified millet starches, CMMS and PGMS, can serve as potential alternatives to conventional excipients in immediate-release formulations and show promising results in optimizing tablet properties.

References

Kar M, Chourasiya Y, Maheshwari R, Tekade RK. Current developments in excipient science. In: Basic fundamentals of drug delivery. Amsterdam: Elsevier; 2019. p. 29-83. doi: 10.1016/B978-0-12-817909-3.00002-9.

Elballa W, Salih M. Influence of partially and fully pregelatinized starch on the physical and sustained-release properties of HPMC-based ketoprofen oral matrices. Int J Pharm Pharm Sci. 2022;14(8):29-34. doi: 10.22159/ijpps.2022v14i8.45031.

Van der Merwe J, Steenekamp J, Steyn D, Hamman J. The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics. 2020;12(5):393. doi: 10.3390/pharmaceutics12050393, PMID 32344802.

Zhong Y, Tian Y, Liu X, Ding L, Kirkensgaard JJ, Hebelstrup K. Influence of microwave treatment on the structure and functionality of pure amylose and amylopectin systems. Food Hydrocoll. 2021;119:106856. doi: 10.1016/j.foodhyd.2021.106856.

Lawal MV. Modified starches as direct compression excipients-effect of physical and chemical modifications on tablet properties: a review. Starch Starke. 2019;71(1-2):1800040. doi: 10.1002/star.201800040.

Sangshetti JN, Deshpande M, Zaheer Z, Shinde DB, Arote R. Quality by design approach: regulatory need. Arab J Chem. 2017;10:S3412-25. doi: 10.1016/j.arabjc.2014.01.025.

Hadidi N, Nazari N, Aboofazeli R. Formulation and optimization of microemulsion-based organogels containing propranolol hydrochloride using experimental design methods. DARU J Pharm Sci. 2015;17(3):217-24.

Jadhav SB, Koshti AR, Bari MM, Barhate SD. Formulation optimization and Evaluation of transdermal patch of losartan potassium containing DMSO as permeation enhancer. Asian J Pharm Technol. 2019;9(3):220-7. doi: 10.5958/2231-5713.2019.00037.0.

Beg S, Swain S, Rahman M, Hasnain MS, Imam SS. Application of design of experiments (DoE) in pharmaceutical product and process optimization. In: Pharm Qual Des Amsterdam: Elsevier; 2019. p. 43-64. doi: 10.1016/B978-0-12-815799-2.00003-4.

Maqlam T, Maad AH, Kadhum AA, Basaeed M. Evaluation of tramadol use in Ibn Sena General Hospital in Mukalla City, Hadhramout governorate, Yemen. J Med Pharm Chem Res. 2024;6(11):1716-24. doi: 10.48309/jmpcr.2024.450324.1174.

Gitau NS. Development and evaluation of pediatric orally disintegrating paracetamol tablets. University of Nairobi; 2019.

Saleemulla K, Ramu G, Mohan GK, Jayaveera KN, Bhalgat C. Tablet disintegrant activities of new starch from immature pepino fruits. J Sci Ind Res. 2011;70:149-55.

Alam S, Bishal A, Bandyopadhyay B. Formulation and evaluation of metformin hydrochloride sustained release matrix tablets. Int J Curr Pharm Res. 2021;13(5):82-8. doi: 10.22159/ijcpr.2021v13i5.1899.

USP C. The United States pharmacopeia. Natl Formul. 2008;14.

Kassaye L, Genete G. Evaluation and comparison of in vitro dissolution profiles for different brands of amoxicillin capsules. Afr Health Sci. 2013;13(2):369-75. doi: 10.4314/ahs.v13i2.25, PMID 24235938.

Usman S. Shehada Mbi, Usman A, Islam Q. Pharmaceutical quality assessment of glimepiride tablets–comparison of brands and newly formulated tablets with innovator. Asian J Pharm Clin Res. 2021;14(10):63-7. doi: 10.22159/ajpcr.2021.v14i10.42768.

Ram D, Pankhaniya H. Formulation, evaluation and optimization of sustained-release drug delivery system of cisapride tablet. Int J Pharm Pharm Sci. 2021;13(9):56-62. doi: 10.22159/ijpps.2021v13i9.41799.

Dino SF, Edu AD, Francisco RG, Gutierrez E, Crucis P, Lapuz AM. Drug-excipient compatibility testing of cilostazol using FTIR and DSC analysis. Philipp J Sci. 2023;152(6A). doi: 10.56899/152.6A.08.

Brubaker J, Moghtadernejad S. A comprehensive review of the rheological properties of powders in pharmaceuticals. Powders. 2024;3(2):233-54. doi: 10.3390/powders3020015.

Okpanachi GO, Musa H, Isah AB. Evaluation of disintegrating property of native and microcrystalline starches derived from digitaria iburua. West Afr J Pharm. 2013;24(1):64-71.

Olayemi O, Oyi A, Allagh T. Comparative evaluation of maize, rice and wheat starch powders as pharmaceutical excipients. Niger J Pharm Sci. 2008;7(1):131-8.

Gbenga BL, Olakunle O, Adedayo AM. Influence of pregelatinization on the physicochemical and compressional characteristics of starches obtained from two local varieties of Dioscorea rotundata. IOSRPHR. 2014;4(6):24-32. doi: 10.9790/3013-040602024032.

Gobinath T. Formulation and evaluation of enteric coated tablets of pantoprazole: JKK Nattraja College of Pharmacy, Komarapalayam. Tamil Nadu, India; 2014.

Mbah CC. Effect of process parameters on the properties of some metronidazole tablet and capsule formulations. Afr J Microbiol Res. 2012;6(24). doi: 10.5897/AJPP11.672.

Gupta A, Hunt RL, Shah RB, Sayeed VA, Khan MA. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution. AAPS Pharm Sci Tech. 2009;10(2):495-9. doi: 10.1208/s12249-009-9227-0, PMID 19387843.

Badwan AA, Rashid I, Al Omari MM, Darras FH. Chitin and chitosan as direct compression excipients in pharmaceutical applications. Mar Drugs. 2015;13(3):1519-47. doi: 10.3390/md13031519, PMID 25810109.

Janssen PH, Fathollahi S, Bekaert B, Vanderroost D, Roelofs T, Vanhoorne V. Impact of material properties and process parameters on tablet quality in a continuous direct compression line. Powder Technol. 2023;424:118520. doi: 10.1016/j.powtec.2023.118520.

Bangar SP, Balakrishnan G, Navaf M, Sunooj KV. Recent advancements on barnyard millet starch: a sustainable alternative to conventional starch. Starch Stärke. 2024;76(9-10):2300232. doi: 10.1002/star.202300232.

Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905. doi: 10.3390/molecules26195905, PMID 34641447.

Published

07-03-2025

How to Cite

AHMED, Y., H. MAAD, A., HASSAN, H. A., ABDALLAH, D. B., YOUSEF, M., H. KADHUM, A. A., & OSMAN, Z. (2025). EVALUATION OF CARBOXYMETHYL MILLET STARCH AND PREGELATINIZED MILLET STARCH AS PHARMACEUTICAL EXCIPIENTS USING FACTORIAL EXPERIMENTAL DESIGNS. International Journal of Applied Pharmaceutics, 17(2), 321–328. https://doi.org/10.22159/ijap.2025v17i2.52161

Issue

Section

Original Article(s)

Similar Articles

<< < 3 4 5 6 7 > >> 

You may also start an advanced similarity search for this article.